본문 바로가기
KERD
논문KCI 등재

Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

OBJECTIVES: Coronavirus disease 2019 (COVID-19) has had a tremendous impact on public health and socioeconomic conditions globally. Although non-pharmaceutical interventions (NPIs) such as social distancing effectively reduced the incidence of COVID-19, especially in Korea, demand for vaccination has increased to minimize the social costs of NPIs. This study estimated the potential benefits of COVID-19 vaccination in Korea.METHODS: A mathematical model with vaccinated–susceptible–latent–infectious–recovered compartments was used to simulate the COVID-19 epidemic. The compartments were stratified into age groups of 0-19 years, 20-59 years, and 60 years or older. Based on the Korea Disease Control and Prevention Agency national vaccination plan for the second quarter of 2021, announced on March 15, we developed vaccination scenarios (with 150,000 dose/d and 100% compliance as the main scenario). Comparing scenarios without vaccination or with higher/lower vaccination rates and compliance, we estimated the numbers of COVID-19 cases that will be prevented by vaccination.RESULTS: The results projected 203,135 cases within a year after April 2021 without vaccination, which would be reduced to 71,248 (64.9% decrease) by vaccination. Supposing a vaccination rate of 150,000 dose/d and 100% compliance, social distancing interventions for those aged 20 or more can be retracted after January 1, 2022.CONCLUSIONS: We expect COVID-19 vaccination to be effective in Korea. Health authorities should minimize delays in vaccination and vaccine avoidance to maximize the effectiveness of vaccination and end social distancing early.

Abstract

OBJECTIVES: Coronavirus disease 2019 (COVID-19) has had a tremendous impact on public health and socioeconomic conditions globally. Although non-pharmaceutical interventions (NPIs) such as social distancing effectively reduced the incidence of COVID-19, especially in Korea, demand for vaccination has increased to minimize the social costs of NPIs. This study estimated the potential benefits of COVID-19 vaccination in Korea.METHODS: A mathematical model with vaccinated–susceptible–latent–infectious–recovered compartments was used to simulate the COVID-19 epidemic. The compartments were stratified into age groups of 0-19 years, 20-59 years, and 60 years or older. Based on the Korea Disease Control and Prevention Agency national vaccination plan for the second quarter of 2021, announced on March 15, we developed vaccination scenarios (with 150,000 dose/d and 100% compliance as the main scenario). Comparing scenarios without vaccination or with higher/lower vaccination rates and compliance, we estimated the numbers of COVID-19 cases that will be prevented by vaccination.RESULTS: The results projected 203,135 cases within a year after April 2021 without vaccination, which would be reduced to 71,248 (64.9% decrease) by vaccination. Supposing a vaccination rate of 150,000 dose/d and 100% compliance, social distancing interventions for those aged 20 or more can be retracted after January 1, 2022.CONCLUSIONS: We expect COVID-19 vaccination to be effective in Korea. Health authorities should minimize delays in vaccination and vaccine avoidance to maximize the effectiveness of vaccination and end social distancing early.

참고문헌 (14)

  1. Dong E, "An interactive web-based dashboard to track COVID-19 in real time", Lancet Infect Dis, 20, pp.533~534 (2020)
  2. "The potential impact of COVID-19 on GDP and trade: a preliminary assessment" (2020)[URL]
  3. 민경덕, "Estimating the Effectiveness of Non-pharmaceutical Interventions on COVID-19 Control in Korea", Journal of Korean Medical Science, 35(35), pp.1~13 (2020), 대한의학회[DOI]
  4. "Statistics and research: coronavirus (COVID-19) vaccinations"[URL]
  5. "Implementation plan for COVID-19 vaccination" (2021)[URL]
  6. Lauer SA, "The incubation period of coronavirus disease 2019(COVID-19)from publicly reported confirmed cases : estimation and application", Ann Intern Med, 172, pp.577~582 (2020)
  7. He X, "Temporal dynamics in viral shedding and transmissibility of COVID-19", Nat Med, 26, pp.672~675 (2020)
  8. Coronavirus disease 2019 (COVID-19) Gyeonggi daily report, "Gyeonggi Infectious Disease Control Center", Gyeonggi Infectious Disease Control Center, 5~ (2020)
  9. Romeijn HE, "Encyclopedia of optimization", pp.3245~3251 (2009), Springer
  10. Baden LR, "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine", N Engl J Med, 384, pp.403~416 (2021)
  11. "Johnson & Johnson COVID-19 vaccine authorized by U.S. FDA for emergency use - first single-shot vaccine in fight against global pandemic"[URL]
  12. Knoll MD, "Oxford-AstraZeneca COVID-19 vaccine efficacy", Lancet, 397, pp.72~74 (2021)
  13. Polack FP, "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine", N Engl J Med, 383, pp.2603~2615 (2020)
  14. Makoni M, "South Africa responds to new SARS-CoV-2 variant", Lancet, 397, pp.267~ (2021)

관련 논문AI추천

이 간행물의 다른 논문 (102건)